The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...

Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy Jr. could ...

Global medical companies are launching hundreds of state-of-the-art technologies in the medical product pavilion of the ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity M ...

Approximately $30 million of this current quarter amount is related to commercial and medical affairs related ... economics ...